Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Recorded changes
86,510 on record
Recorded policy changes, newest first| Recorded | Payer | Policy | Change |
|---|
| May 14, 2026 | HealthPartners | Cerliponase alfa (Brineura) – Minnesota Health Care ProgramsPayerPolicy · HEALTHPARTNERS-CC-ENTRY-203016 | New policy |
|---|
| May 14, 2026 | HealthPartners | Cerliponase alfa (Brineura)PayerPolicy · HEALTHPARTNERS-CC-ENTRY-197091 | New policy |
|---|
| May 14, 2026 | HealthPartners | Category III CPT codesPayerPolicy · HEALTHPARTNERS-CC-AENTRY-046311 | New policy |
|---|
| May 14, 2026 | HealthPartners | Casimersen (Amondys 45) – Minnesota Health Care ProgramsPayerPolicy · HEALTHPARTNERS-CC-ENTRY-237356 | New policy |
|---|
| May 14, 2026 | HealthPartners | Casimersen (Amondys 45)PayerPolicy · HEALTHPARTNERS-CC-ENTRY-237355 | New policy |
|---|
| May 14, 2026 | HealthPartners | Cardiovascular risk assessmentsPayerPolicy · HEALTHPARTNERS-CC-AENTRY-045874 | New policy |
|---|
| May 14, 2026 | HealthPartners | Cardiac event monitoringPayerPolicy · HEALTHPARTNERS-CC-AENTRY-045835 | New policy |
|---|
| May 14, 2026 | HealthPartners | Capsaicin patch (Qutenza) – Minnesota Health Care ProgramsPayerPolicy · HEALTHPARTNERS-CC-ENTRY-223232 | New policy |
|---|
| May 14, 2026 | HealthPartners | Canakinumab (Ilaris)PayerPolicy · HEALTHPARTNERS-CC-ENTRY-204622 | New policy |
|---|
| May 14, 2026 | HealthPartners | Burosumab (Crysvita) – Minnesota Health Care ProgramsPayerPolicy · HEALTHPARTNERS-CC-ENTRY-204623 | New policy |
|---|
| May 14, 2026 | HealthPartners | Burosumab (Crysvita)PayerPolicy · HEALTHPARTNERS-CC-ENTRY-202452 | New policy |
|---|
| May 14, 2026 | HealthPartners | Brexanolone (Zulresso)PayerPolicy · HEALTHPARTNERS-CC-ENTRY-210232 | New policy |
|---|
| May 14, 2026 | HealthPartners | Breast surgeryPayerPolicy · HEALTHPARTNERS-CC-AENTRY-045829 | New policy |
|---|
| May 14, 2026 | HealthPartners | Breast prosthesisPayerPolicy · HEALTHPARTNERS-CC-AENTRY-045824 | New policy |
|---|
| May 14, 2026 | HealthPartners | Botulinum toxins: abobotulinumtoxinA (Dysport), incobotulinumtoxinA (Xeomin), onabotulinumtoxinA (Botox), rimabotulinumtoxinB (Myobloc), and daxibotulinumtoxinA-lanm (Daxxify)PayerPolicy · HEALTHPARTNERS-CC-AENTRY-045822 | New policy |
|---|
| May 14, 2026 | HealthPartners | Botulinum toxins: abobotulinumtoxinA (Dysport), incobotulinumtoxinA (Xeomin), onabotulinumtoxinA (Botox), and rimabotulinumtoxinB (Myobloc) – Minnesota Health Care ProgramsPayerPolicy · HEALTHPARTNERS-CC-ENTRY-197060 | New policy |
|---|
| May 14, 2026 | HealthPartners | Bone-anchored hearing aids – Minnesota Health Care ProgramsPayerPolicy · HEALTHPARTNERS-CC-AENTRY-045943 | New policy |
|---|
| May 14, 2026 | HealthPartners | Bone growth stimulator, electrical and ultrasonic - Minnesota Health Care ProgramsPayerPolicy · HEALTHPARTNERS-CC-AENTRY-045821 | New policy |
|---|
| May 14, 2026 | HealthPartners | Bone growth stimulator, electrical and ultrasonicPayerPolicy · HEALTHPARTNERS-CC-AENTRY-045820 | New policy |
|---|
| May 14, 2026 | HealthPartners | Bone anchored hearing aids (BAHA)PayerPolicy · HEALTHPARTNERS-CC-AENTRY-045941 | New policy |
|---|
| May 14, 2026 | HealthPartners | Blood factor and non-factor products for hemophilia and other clotting disordersPayerPolicy · HEALTHPARTNERS-CC-AENTRY-045817 | New policy |
|---|
| May 14, 2026 | HealthPartners | Blepharoplasty, blepharoptosis repair, and brow liftPayerPolicy · HEALTHPARTNERS-CC-AENTRY-045815 | New policy |
|---|
| May 14, 2026 | HealthPartners | Biologics requiring IV induction dosingPayerPolicy · HEALTHPARTNERS-CC-ENTRY-287210 | New policy |
|---|
| May 14, 2026 | HealthPartners | Biologics for chronic inflammatory diseasesPayerPolicy · HEALTHPARTNERS-CC-ENTRY-182852 | New policy |
|---|
| May 14, 2026 | HealthPartners | Biologics for allergy and pulmonologyPayerPolicy · HEALTHPARTNERS-CC-ENTRY-287232 | New policy |
|---|
| May 14, 2026 | HealthPartners | BiofeedbackPayerPolicy · HEALTHPARTNERS-CC-AENTRY-045657 | New policy |
|---|
| May 14, 2026 | HealthPartners | Bezlotoxumab (Zinplava)PayerPolicy · HEALTHPARTNERS-CC-ENTRY-191265 | New policy |
|---|
| May 14, 2026 | HealthPartners | Belatacept (Nulojix) – Minnesota Health Care ProgramsPayerPolicy · HEALTHPARTNERS-CC-ENTRY-203023 | New policy |
|---|
| May 14, 2026 | HealthPartners | Balloon sinus ostial dilation (balloon sinuplasty)PayerPolicy · HEALTHPARTNERS-CC-ENTRY-274247 | New policy |
|---|
| May 14, 2026 | HealthPartners | Axatilimab-csfr (Niktimvo)PayerPolicy · HEALTHPARTNERS-CC-ENTRY-285876 | New policy |
|---|
| May 14, 2026 | HealthPartners | Automatic external defibrillator – Minnesota Health Care ProgramsPayerPolicy · HEALTHPARTNERS-CC-AENTRY-046210 | New policy |
|---|
| May 14, 2026 | HealthPartners | Automatic external defibrillatorPayerPolicy · HEALTHPARTNERS-CC-AENTRY-046209 | New policy |
|---|
| May 14, 2026 | HealthPartners | Autologous chondrocyte implantation (ACI)PayerPolicy · HEALTHPARTNERS-CC-AENTRY-045627 | New policy |
|---|
| May 14, 2026 | HealthPartners | Authorized care outside the service areaPayerPolicy · HEALTHPARTNERS-CC-AENTRY-045628 | New policy |
|---|
| May 14, 2026 | HealthPartners | Augmentative communication device - Minnesota Health Care ProgramsPayerPolicy · HEALTHPARTNERS-CC-AENTRY-045650 | New policy |
|---|
| May 14, 2026 | HealthPartners | Augmentative communication devicePayerPolicy · HEALTHPARTNERS-CC-AENTRY-045649 | New policy |
|---|
| May 14, 2026 | HealthPartners | Atypical antipsychotic injections (Aristada, and Zyprexa Relprevv) – Minnesota Health Care ProgramsPayerPolicy · HEALTHPARTNERS-CC-ENTRY-203025 | New policy |
|---|
| May 14, 2026 | HealthPartners | Asparaginase erwinia chrysanthemi (recombinant) - rywn (Rylaze) - Minnesota Health Care ProgramsPayerPolicy · HEALTHPARTNERS-CC-ENTRY-247646 | New policy |
|---|
| May 14, 2026 | HealthPartners | Artificial intervertebral disc replacementPayerPolicy · HEALTHPARTNERS-CC-AENTRY-046447 | New policy |
|---|
| May 14, 2026 | HealthPartners | Anifrolumab (Saphnelo) and belimumab (Benlysta)PayerPolicy · HEALTHPARTNERS-CC-AENTRY-045989 | New policy |
|---|
| May 14, 2026 | HealthPartners | Anesthesia services for routine gastrointestinal endoscopic proceduresPayerPolicy · HEALTHPARTNERS-CC-ENTRY-184408 | New policy |
|---|
| May 14, 2026 | HealthPartners | Amyloid monoclonal antibodiesPayerPolicy · HEALTHPARTNERS-CC-ENTRY-237330 | New policy |
|---|
| May 14, 2026 | HealthPartners | Ambulance and medical transportationPayerPolicy · HEALTHPARTNERS-CC-AENTRY-045641 | New policy |
|---|
| May 14, 2026 | HealthPartners | Alpha-1 antitrypsin (AAT) deficiency enzyme replacement therapy: alpha-1 proteinase inhibitor (Aralast NP, Glassia, Prolastin-C, and Zemaira) - Minnesota Health Care ProgramsPayerPolicy · HEALTHPARTNERS-CC-ENTRY-187801 | New policy |
|---|
| May 14, 2026 | HealthPartners | Alpha-1 antitrypsin (AAT) deficiency enzyme replacement therapy: alpha-1 proteinase inhibitor (Aralast NP, Glassia, Prolastin-C, and Zemaira)PayerPolicy · HEALTHPARTNERS-CC-AENTRY-045614 | New policy |
|---|
| May 14, 2026 | HealthPartners | Allogeneic processed thymus tissue–agdc (Rethymic)PayerPolicy · HEALTHPARTNERS-CC-ENTRY-249239 | New policy |
|---|
| May 14, 2026 | HealthPartners | Allergy testing/immunotherapyPayerPolicy · HEALTHPARTNERS-CC-AENTRY-045638 | New policy |
|---|
| May 14, 2026 | HealthPartners | Alemtuzumab (Lemtrada) – Minnesota Health Care ProgramsPayerPolicy · HEALTHPARTNERS-CC-ENTRY-205426 | New policy |
|---|
| May 14, 2026 | HealthPartners | Alemtuzumab (Lemtrada)PayerPolicy · HEALTHPARTNERS-CC-AENTRY-045637 | New policy |
|---|
| May 14, 2026 | HealthPartners | Airway clearance system/ high frequency chest wall compression system – Minnesota Health Care ProgramsPayerPolicy · HEALTHPARTNERS-CC-ENTRY-191830 | New policy |
|---|